神經(jīng)生物學(xué)論文-帕金森氏病的治療研究進展-資料下載頁
2025-04-07 03:58本頁面
【正文】 P, Forraz N, Allouard al. (2004) Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res 295:350–359. D, Tsirimonaki E, Vallianatos al. (2006) Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells. J Neurosci Res 83:1190–1200. D, Shamblott MJ, Fox al. (2005) Transplanted human embryonic germ cellderived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage. J Neurosci Res 82:592–608. S, Kim EY, Ghil al. (2003) Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson’s disease. Neurosci Lett 353:91–94. M, ItskovitzEldor J, Benvenisty N. (2003) Selective ablation of human embryonic stem cells expressing a “suicide” gene. Stem cells 21:257–265. KC, Pruszak J, Yoshizaki al. (2007) Enhanced yield of neuroepithelial precursors and midbrainlike dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem cells 25:411–418. JA, ItskovitzEldor J, Shapiro al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147. F, Cui L, Johkura al. (2006) Induction of midbrain dopaminergic neurons from primate embryonic stem cells by coculture with sertoli cells. Stem Cells 24:1695–1706. S, Caillaud C, Vigne al. (1993) Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3:224–228. R, Kordower JH, Kane al. (1995) Neural transplantation of cells expressing the antiapoptotic gene bcl2. Cell Transplant 4:49–54. M, Ralph S, Wong al. (2004) Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector. Neuroreport 15:985–990. JC, Deglon N, Tseng al. (2000) Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6OHDA model of Parkinson’s disease using GDNF. Exp Neurol 164:15–24. A, Lindvall O (2000) Parkinson disease gene therapy moves toward the clinic. Nat Med 6:1207–1208. EA, Glorioso JC, Fink DJ (2003) Gene therapy progress and prospects: Parkinson’s disease. Gene Ther 10:1721–1727. DL, Lin Q, Chang al. (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838–841. CB, Barker RA (2004) The potential of GDNF as a treatment for Parkinson’s disease. Exp Neurol 185:1–6. D, Georgievska B, Bj246。rklund A (2004) Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat Neurosci 7:105–110.
化學(xué)相關(guān)推薦
鄂ICP備17016276號-1